Abiopharma

🔍 Keel Paul A (Director)

Company: Envista Holdings Corp (NVST)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Acquired 179,730 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 551,304.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 159,900 shares of Performance Share Unit (Derivative)
  Date: 2026-08-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 159,900.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2

Footnotes:

• F1: Consists of Restricted Stock Units ("RSU") that will vest ratably on each anniversary of the date of grant over four years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.
• F2: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a four-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 75%-125% of the amount reported depending on the level of performance achieved.